Table 1 |
|||
|
Top 20 positive GGM edge weights (i.e. partial correlation coefficients, PCC) in our data set along with proposed metabolic pathway explanations |
|||
|
Metabolite 1 |
Metabolite 2 |
PCC |
Comment |
|
|
|||
|
Val |
xLeu |
0.821 |
Branched-chain amino acids |
|
SM C18:0 |
SM C18:1 |
0.767 |
SCD/SCD5 desaturation |
|
SM C16:1 |
SM C18:1 |
0.765 |
ELOVL6 |
|
PC ae C34:2 |
PC ae C36:3 |
0.752 |
2 reaction steps |
|
SM (OH) C22:1 |
SM (OH) C22:2 |
0.743 |
sphingolipid-specific desaturation? |
|
PC aa C34:2 |
PC aa C36:2 |
0.735 |
ELOVL1/ELOVL6 elongation |
|
C10:0-carn |
C8:0-carn |
0.735 |
β-oxidation step |
|
lysoPC a C16:0 |
lysoPC a C18:0 |
0.731 |
ELOVL6 elongation |
|
PC aa C38:6 |
PC aa C40:6 |
0.709 |
ACOX1/3 + various ELOVLs |
|
SM (OH) C14:1 |
SM (OH) C16:1 |
0.686 |
sphingolipid-specific elongation? |
|
PC aa C36:4 |
PC aa C38:4 |
0.672 |
ACOX1/3 + various ELOVLs |
|
PC aa C32:1 |
lysoPC a C16:1 |
0.661 |
C16:0/C16:1 phospholipid association |
|
PC aa C38:5 |
PC aa C40:5 |
0.653 |
various ELOVLs |
|
PC ae C34:3 |
PC ae C36:5 |
0.607 |
at least 3 reaction steps |
|
PC aa C36:5 |
PC aa C38:5 |
0.596 |
ACOX1/3 + various ELOVLs |
|
SM C24:0 |
SM C24:1 |
0.577 |
sphingolipid-specific desaturation? |
|
PC ae C32:1 |
PC ae C32:2 |
0.574 |
SCD/SCD5 desaturation |
|
SM (OH) C22:2 |
SM C24:1 |
0.567 |
possible elongation intermediate |
|
C18:1-carn |
C18:2-carn |
0.561 |
β-oxidation intermediate |
|
|
|||
|
Most metabolite pairs can be directly linked to reactions in the fatty acid biosynthesis pathway, the β-oxidation pathway or amino acid-associated pathways. |
|||
|
Krumsiek et al. BMC Systems Biology 2011 5:21 doi:10.1186/1752-0509-5-21 |
|||